Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ACMR | Class A Common Stock, $0.0001 par value | Sale | -$12.3M | -571K | -16.77% | $21.52 | 2.83M | Oct 4, 2024 | Direct | F1, F2 |
transaction | ACMR | Class A Common Stock, $0.0001 par value | Sale | -$2.71M | -129K | -4.56% | $20.94 | 2.7M | Oct 4, 2024 | Direct | F3 |
transaction | ACMR | Class A Common Stock, $0.0001 par value | Sale | -$2.55M | -101K | -3.72% | $25.36 | 2.6M | Oct 7, 2024 | Direct | F4 |
transaction | ACMR | Class A Common Stock, $0.0001 par value | Sale | -$37.1K | -1.48K | -0.06% | $25.02 | 2.6M | Oct 7, 2024 | Direct | F5 |
transaction | ACMR | Class A Common Stock, $0.0001 par value | Sale | -$4.03M | -173K | -6.65% | $23.32 | 2.43M | Oct 7, 2024 | Direct | F6 |
transaction | ACMR | Class A Common Stock, $0.0001 par value | Sale | -$1.91M | -90.4K | -3.72% | $21.13 | 2.34M | Oct 8, 2024 | Direct | F7 |
holding | ACMR | Class A Common Stock, $0.0001 par value | 3.36M | Oct 4, 2024 | Through Shanghai Pudong Science & Technology Investment Group Co., Ltd. | F8, F9 |
Shanghai Science & Technology Venture Capital (Group) Co., Ltd. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 7 of this Form 4. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.11 to $22.10, inclusive. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.71 to $21.10, inclusive. |
F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.03 to $26.02, inclusive. |
F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.01 to $25.02, inclusive. |
F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.05 to $23.91, inclusive. |
F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.53 to $21.51, inclusive. |
F8 | This Form 4 is being filed by the undersigned as well as Shanghai Pudong Science & Technology Investment Group Co., Ltd., as set forth on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Shanghai Science & Technology Venture Capital (Group) Co., Ltd. holds a 46% equity interest in Shanghai Pudong Science & Technology Investment Group Co., Ltd. |
F9 | In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Reporting Persons is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. |
The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by Shanghai Science & Technology Venture Capital (Group) Co., Ltd. on June 12, 2024.